Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07058064 · ClinicalTrials.gov registry record · NA

WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)

A NA study of Lymphoma and Sarcoma, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT07058064 is a NA study of Lymphoma and Sarcoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 250 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07058064, a NA study of Lymphoma and Sarcoma, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to find a cost effective cardiovascular (CV) surveillance of cancer survivors over long periods of time to prevent the risk of progression of heart failure (HF) and related morbidity and mortality. Mobile device-based artificial intelligence (AI)-electrocardiogram (ECG) can reliably detect cardiac dysfunction in lymphoma and sarcoma survivors and smart watch based surveillance for cardiotoxicity is feasible and reliable.

Conditions Studied

Lymphoma Sarcoma

Interventions

  • PROCEDURE Electrocardiogram
  • PROCEDURE Echocardiogram
  • PROCEDURE LVEF echocardiogram
  • OTHER Apple Watch
  • PROCEDURE Biospecimen collection

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2025-07-18
Est. Completion 2029-06-29
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07058064

The ClinicalTrials.gov registry entry for NCT07058064 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (48% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Lymphoma appearing as the primary indexed condition, and to 5 interventions - of which Electrocardiogram is the first listed.

NCT07058064 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07058064 about?

NCT07058064 is a clinical study titled "WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)". The purpose of this study is to find a cost effective cardiovascular (CV) surveillance of cancer survivors over long periods of time to prevent the risk of progression of heart failure (HF) and related morbidity and mortality. Mobile device-based artificial intelligence (AI)-electrocardiogram (ECG) ...

What is the current status of trial NCT07058064?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2025-07-18. Estimated completion is 2029-06-29.

What conditions does trial NCT07058064 study?

This clinical trial studies the following conditions: Lymphoma, Sarcoma.

What interventions are being tested in trial NCT07058064?

The interventions under investigation include: Electrocardiogram (PROCEDURE), Echocardiogram (PROCEDURE), LVEF echocardiogram (PROCEDURE), Apple Watch (OTHER), Biospecimen collection (PROCEDURE).

Who is sponsoring clinical trial NCT07058064?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07058064 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lymphoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lymphoma

All registered trials for this condition

Sarcoma

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.